In early pregnancy, human extravillous trophoblasts (EVTs) invade and remodel maternal arteries.
Introduction
In the human placenta, cytotrophoblasts show two distinct patterns of differentiation. In floating villi, cytotrophoblasts differentiate into syncytiotrophoblast and form the syncytial layer, while at villus-anchoring sites, cytotrophoblasts differentiate into extravillous trophoblasts (EVTs) and form the stratified structure called the cell column. After EVTs lose proliferative activity and acquire migratory activity in the cell column 1 , the cells begin to migrate into the decidual tissue (interstitial trophoblasts) or toward maternal blood vessels. Interestingly, EVT migration is directed preferentially to the uterine spiral arteries 2 .
EVTs that migrate around the blood vessels (perivascular trophoblasts) destroy the muscular linings and those that migrate along the vascular lumen (endovascular trophoblasts) replace the endothelium.
Thus, the maternal arteries are remodeled into low-resistance tubes that are unable to constrict. This process ensures adequate placental perfusion and contributes to the successful establishment of pregnancy 3 . In fact, insufficient physiological remodeling has been reported in cases of preeclampsia and intrauterine fetal growth retardation 4 . In contrast to other organ constructions in the embryo and placenta, this extraembryonic tissue remodeling occurs in maternal tissues and requires both maternal and embryo-derived cells for cooperative tissue construction. From this perspective, this process is more complex than those involved in organ development during embryogenesis.
Vascular infiltration of EVTs at the implantation site is mainly observed in humans and primates 2 . Therefore, analysis of the mechanism is difficult and has been poorly understood for a long time. The predominant EVT migration toward maternal arteries suggests that some factor(s) derived from the endothelium or blood constituents direct this migration. It has been proposed that the relatively high oxygen tension in maternal arteries promotes 5 . This theory could explain, at least in part, why EVT invasion is directed toward the uterine arteries.
However, some reports demonstrated that EVTs become more invasive under hypoxic conditions 6 . Thus, hypotheses about the molecular mechanisms that regulate trophoblast invasion and uteroplacental artery remodeling remain controversial 7 .
We previously reported that trophoblasts acquire a chemokine receptor, CCR1, as they differentiate towards EVTs, and that migration of EVTs is promoted by CCR1 ligands such as RANTES and MIP-1α 8 . EVTs also decreased the expression of dipeptidyl peptidase IV/CD26, which can degrade chemokines including RANTES 9, 10 . Notably, peri/endovascular trophoblasts in the shallow sites expressed CCR1 more intensely than interstitial trophoblasts.
CCR-1 expression was specifically limited to the EVTs that migrated from the distal site of the cell column in the anchoring villi into spiral arteries through the shell that covered the peripheral sites of the maternal decidua 8 . This suggests that chemokines are candidate factors supporting trophoblastic vascular infiltration. Therefore, we immunohistochemically examined possible production sites of CCR1 ligands in maternal tissues. Our immunohistochemical study, however, did not detect dominant localization of chemokine-expressing cells around/within the maternal vessels 8 .
Recently, human platelets have been shown to release several chemoattractants including chemokines 11 . Since platelets lose their stored substances immediately after activation, it is no wonder that we could not detect immunoreactive chemokines in platelets at the feto-maternal interface.
Moreover, platelet activation is known to occur near damaged blood vessels.
Thus, we considered that platelets might be the sources of chemoattractants such as chemokines that support trophoblastic vascular infiltration. To investigate this possibility, we examined the immunohistochemical localization of platelets 
Materials and Methods

Tissue samples
Human endometrial and placental tissues for immunohistochemistry were obtained from eight therapeutic hysterectomies performed for cervical neoplasia or uterine myoma during the secretory phase (n=3) and normal pregnancies (9 and 10 weeks of gestation n=5 
Reagents and antibodies
An ELISA kit to measure the concentration of human RANTES was obtained from Biosource International (Camarillo, CA). Function-perturbing mouse anti-human CCR1 monoclonal antibody (mAb) (clone 141-2) was purchased from MBL (Nagoya, Japan 
Isolation and culture of human platelets and PBMC
Human platelets and PBMC were isolated as described previously 13, 14 .
Whole These platelets and PBMC were cultured in collagen type I-coated 6-well plates (Iwaki, Chiba, Japan) for 24 hours to collect platelet-conditioned medium (CM) or PBMC-CM.
Human chorionic villous explant culture and isolation of extravillous trophoblasts (EVTs)
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EVTs that grew from explanted human chorionic villi were isolated as previously described 8 . Briefly, placental tissues were aseptically dissected to remove decidual tissues and fetal membrane. The remaining chorionic villi were minced into about 2-mm fragments, soaked in FCS (Gibco) and individually placed in 10-cm dishes coated with collagen type I (Iwaki). After 4 hours of incubation to allow the explants to adhere, 10 mL of RPMI containing 
Long-term co-culture of the isolated EVTs with platelets or PBMC
The isolated EVTs (2 x 10 5 cells/2 mL of RPMI with 1% FCS) were plated in collagen type I-coated 6-well plates. PBMC (2 x 10 6 cells/mL) or platelets (2 x 10 8 cells/mL) in RPMI were inoculated into the culture insert (Becton Dickinson), which had a 0.4-µm-pore membrane filter that was pre-coated with collagen type I (Koken, Tokyo, Japan, 1 µg/mL) and were co-cultured with the isolated EVTs. After incubation for 48 hours, changes in
EVTs were observed and analyzed by flow cytometry. For morphological
For personal use only. on January 1, 2018. by guest www.bloodjournal.org From analysis, the isolated EVTs were plated in collagen type I-coated 24-well plates with the 0.4-µm-pore membrane culture insert in the presence or absence of PBMC or platelets in triplicate and the calculated length/width ratio as described below. These experiments were repeated 5 times.
In some cases, the isolated EVTs were directly incubated with or without platelets in the absence of a culture insert. After 24-hour culture, EVTs were detached using scrapers and suspended in HBSS (Gibco) . Differences between the mean intensity of integrin α1 or integrin α5 expression levels were analyzed by two-tailed paired t test.
Matrigel invasion assay
Invasion assay was carried out as previously described 8 . A These experiments were performed in duplicate and the average was defined as the invading cell number. Each result was expressed as the percentage of invading cell number in the control (without co-culture or additive). The experiment was repeated at least three times using EVTs that had been isolated from distinct chorionic explant cultures at different gestational ages (6-9 weeks). The differences were analyzed by one-way ANOVA followed by Scheffe's F-test for multiple comparisons. were calculated. The cell size (area) was also calculated using NIH Image 1.61.
Differences among treatment groups in 5 independent experiments were analyzed by one-way ANOVA followed by Scheffe's F-test for multiple comparisons.
In some wells of 96-well plates, the cells were allowed to attach to collagen type I for 30 min, then washed once with RPMI, and the number of attached cells in each well was assessed using the Premix WST-1 Cell
13
Proliferation Assay System (Takara, Kusatsu, Japan) and ELISA plate reader (Molecular Device, Menlo Park, CA) according to the manufacturer's instructions. In other wells of the 96-well plates, the cells were cultured for 12 hours, washed twice with RPMI, and the number of viable cells in each well was assessed. Alternatively, the cell lysate was collected from each well and the number of apoptotic cells was assessed using Cell Death Detection ELISA Plus (Roche Molecular Biochemicals, Mannheim, Germany) and ELISA plate reader according to the manufacturer's instructions. These experiments were repeated at least three times and performed in duplicate, then the average was defined as the "attached cell number", "viable cell number" or "apoptotic cell number".
Each result was expressed as the percentage of the cell number in the control (without additive). The differences were analyzed by one-way ANOVA followed by Scheffe's F-test for multiple comparisons.
Gelatin zymography
Gelatin zymography was performed as previously described 17 . Twenty microliters of culture medium harvested from the upper well of the invasion assay performed as described above were electrophoresed under non-reducing conditions in a 7.5% SDS-acrylamide gel containing 2 mg/mL gelatin (Difco).
After electrophoresis, the gel was washed, incubated at 37 o C overnight in buffer containing 150 mM NaCl, 5mM CaCl2, 0. For
Results
Localization of platelets and leukocytes at human feto-maternal interface
To determine the localization of platelets or leukocytes at the feto-maternal interface, we immunostained human placental tissues at 9 (n=3) and 10 (n=2) weeks of gestation with anti-CD41 mAb or anti-CD45 mAb, respectively. As shown in Fig. 1B-D , platelets were confined within the maternal blood vessels that contained endovascular trophoblasts, while leukocytes were diffusely distributed throughout the maternal interstitium.
These platelets were attached to the surface of the endovascular trophoblasts or to vessel walls that were infiltrated by perivascular trophoblasts (Fig. 1E ).
Since it is well known that platelets become activated when they are attached to ECM, the expressions of collagen type I, collagen type IV and fibronectin were examined in adjacent sections. Immunohistochemistry showed that all of these three ECM components were diffusely expressed in the maternal interstitium, including the subendothelial region. In addition, collagen type IV and fibronectin were expressed on the surface of endovascular trophoblasts in the spiral arteries ( Fig. 1F and G) . Although CD 45-positive immune cells were distributed around spiral arteries, there were no platelets observed within spiral arteries in the endometrium during the secretory phase in non-pregnant women ( Fig. 1H and I ).
Co-localization of P-selectin and CD41 on platelets adhering to endovascular trophoblasts and cultured EVTs
In the maternal spiral arteries, immunohistochemical double-staining showed that P-selectin was co-localized with CD-41 on platelets that adhered to endovascular trophoblasts ( Fig. 2A-D) .
After 24-hour culture of isolated EVTs with platelets,
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Short-term effects of platelet-and PBMC-derived soluble factors on isolated human EVTs
Co-culturing with human platelets but not with PBMC significantly enhanced Matrigel invasion of isolated human EVTs (Fig. 3A) , without affecting their secretion of MMP-2 or MMP-9 (Fig. 3B) . Similarly, platelet-conditioned medium (CM) enhanced the invasive activity of EVTs in a dose dependent manner, while PBMC-CM did not (Fig. 3C ).
On collagen type I, neither platelet-CM nor PBMC-CM affected the attachment of EVTs (data not shown). After 12 hours of culturing on collagen
type I, the number of viable cells (viability) was significantly increased (Fig.   4A ) and the number of apoptotic cells was significantly decreased in the presence of PBMC-CM (Fig. 4B ), but such effects were not observed with platelet-CM.
The invasion-promoting effect of platelet-CM on isolated EVTs was completely abrogated by heat treatment but not changed by charcoal stripping (Fig. 4C) . Interaction of chemokine receptor CCR1 and its ligands has been demonstrated to promote EVT invasion 8 . To examine the possible contribution of CCR1 ligands to the invasion-promoting effect of platelet-CM, we disrupted the bioactivity of CCR1 on the isolated EVTs using an anti-CCR1 function-perturbing antibody. Pre-incubation of isolated EVTs with the anti-CCR1 antibody significantly reduced the invasion-promoting effect of platelet-CM (Fig 4D) .
Long-term effects of platelet-and PBMC-derived soluble factors on the isolated human EVTs
To examine the possible effects of PBMC-or platelet-derived soluble factors on EVT differentiation, isolated human EVTs were co-cultured with human PBMC or platelets for a longer period (48 hours). Without co-culturing, the shape of isolated EVTs became extremely elongated after 48 hours, resembling that of interstitial trophoblasts in vivo (Fig. 5A, left panel) . The shape of isolated EVTs that had been co-cultured with the platelets for 48 hours became rather round, resembling the shape of endovascular trophoblasts in vivo (Fig. 5A, right panel) . These morphological changes were also confirmed by the length/width ratio (Fig. 5D ). There was no difference in cell size (data not shown). Flow cytometric analysis demonstrated that these round EVTs expressed higher levels of integrin α1 than control elongated EVTs (Fig. 5B, mean intensity 180.543±32.557 vs. 122.817±17.868, p<0.05), while there was no significant change in integrin α5 expression (data not shown). When co-cultured with PBMC, integrin α1 expression was not changed (data not shown), but integrin α5 expression was significantly lower than that of controls (Fig. 5C, mean 
Discussion
In this study, we examined the localization of leukocytes and platelets in frozen sections of early human placental tissues. Immunohistochemistry showed that leukocytes (CD45-positive cells) were diffusely distributed throughout the maternal interstitium. In contrast, platelets (CD41-positive cells) were confined within maternal vessels containing endovascular trophoblasts. We could detect immunoreactive α-smooth muscle actin around these vessels, indicating that the vessels were arteries and not veins (data not shown). In spiral arteries of non-pregnant women, there were no platelets detected. In pregnant women, these platelets were attached to the surface of endovascular trophoblasts or to vessel walls that were infiltrated by perivascular trophoblasts. The expression of ECM components such as collagen type IV and fibronectin was observed on the surface of endovascular trophoblasts as well as in the subendothelium. Considering that ECM can effectively trigger platelet activation 18 , these platelets are likely to have been activated and to have released various bioactive substances. During activation, platelets transport P-selectin from the cytoplasmic region to cell surface. Therefore, to support the above speculation, we confirmed that platelets that were directly incubated with isolated EVTs adhered to these EVTs and that the adherent platelets expressed P-selectin on their cell surface, showing that platelets have become activated.
On invasion assays, we found that platelets significantly increased the number of human EVTs invading through Matrigel without affecting proliferation of EVTs. A similar invasion-promoting effect was observed in conditioned medium (CM) harvested from human platelet cultures. In contrast to platelet-CM, PBMC-CM had no significant effect on invasion of EVTs.
Although the number of viable cells was significantly higher, the number of It is widely considered that EVTs undergo differentiation even after these cells enter the maternal tissue 20 . The shape of endovascular trophoblasts seems to be round and distinct from the surrounding perivascular trophoblasts that are spindle-shaped (see Fig. 1E -G). Moreover, it has been reported that endovascular trophoblasts express higher levels of integrin α1 than interstitial trophoblasts 21 . Here, we found that isolated EVTs became round when co-cultured with platelets for a longer period (48 hours). These cells differed from elongated EVTs observed after culturing without platelets. These round EVTs expressed higher levels of integrin α1 than the elongated EVTs. These findings suggest that platelet-derived soluble factors may induce EVT differentiation toward the endovascular phenotype.
Thrombophilic disorders are well known to be associated with recurrent fetal loss, preeclampsia, and intrauterine fetal growth retardation 22 . Although platelet activation is considered nonspecific for EVTs, but a general phenomenon of ECM-secreting cells, according to past reports, trophoblasts abundantly express thrombomodulin 23 and tissue-and urokinase-type plasminogen activators [24] [25] [26] that can inhibit the coagulation pathway and effect the rapid degradation of fibrin at the trophoblastic surface. In preeclampsia and/or intrauterine fetal growth retardation, where trophoblasts have been reported to possess lower activity of plasminogen activators 27 , the maternal spiral arteries exhibit acute necrotizing arteriopathy (acute atherosis) with frequent thrombosis 28 . Therefore, it is possible that in normal pregnancy,
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intravascular thrombus formation may be prevented by peri/endovascular trophoblasts despite the presence of platelets that have been activated by ECM.
Our previous study demonstrated that EVTs express a chemokine receptor, CCR1, and that CCR1 ligands such as RANTES, MIP-1α, MCP-2, and HCC-1 significantly enhanced the migration of EVTs using the same cell culture and invasion assay systems 8 . In addition, it was reported that platelets contain MIP-1α and MCP-3, which are also CCR-1 ligands 11 . In the present study, pretreatment with anti-CCR1 function perturbing antibody significantly inhibited the enhanced EVT migration towards platelet-CM, indicating that platelet-CM promotes EVT migration at least in part through the action of the chemokine-CCR1 system in vitro. Taken together with the fact that CCR1 expression was more intense on peri/endovascular trophoblasts as compared with interstitial trophoblasts 8 , it is speculated that the interaction of trophoblastic CCR1 and chemokines released by activated maternal platelets play an important role in trophoblastic arterial infiltration.
In this study, platelet-CM-stimulated EVT migration was not completely inhibited by CCR1 neutralization. These results suggest that some platelet-derived soluble factors other than chemokines are also responsible for the promotion of EVT migration. Previous studies by other investigators demonstrated that EGF, VEGF, and PDGF, all of which are released from activated platelets 29 , could enhance trophoblastic invasion 30, 31 . Recently, it was reported that activated platelets release abundant amounts of a lipid mediator, sphingosine-1-phosphate (S1P), which regulates the migration of various cell types 32 . However, lipid removal from platelet-CM by charcoal stripping had no significant effect on its migration-promoting activity, while inactivation of bioactive peptides by heat treatment completely abrogated the activity. These findings suggest that some protein factors such as chemokines, not lipid factors, were due to the biological effects of platelet-derived CM on EVTs towards platelet-conditioned medium (CM) with or without heat treatment or charcoal stripping in the presence or absence of anti-CCD1 mAb was assessed as described in Materials and Methods. The invasion-promoting effect of platelet-CM on isolated EVTs was completely abrogated by heat treatment but not changed by charcoal stripping (Fig. 4C) . Pre-incubation of isolated EVTs with the anti-CCR1 antibody significantly reduced the invasion-promoting effect of platelet-CM (Fig 4D) . * indicates p<0.05, **indicates p<0.01 and NS indicates "not significant. For personal use only. on January 1, 2018. by guest www.bloodjournal.org From
